Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer's disease: results of a randomized, double-blind, placebo-controlled phase 2a study Journal Articles Refereed uri icon

Overview

Authors

  • Authorship

    • SCHELTENS P
    • VAN BAAL CM
    • BRUINS S
    • LUES I
    • PRINS ND
    • HALLIKAINEN M
    • GRIMMER T
    • DUNING T
    • GOUW AA
    • TEUNISSEN CE
    • WINK AM
    • PROF Paul Maruff
    • HARRISON J

Published in

  • Alzheimer's Research & Therapy

Time

Date/time value

  • 2018

Identity

Digital Object Identifier (DOI)

  • 10.1186/s13195-018-0431-6

Additional Document Info

Parent Title

  • ALZHEIMERS RESEARCH & THERAPY

Volume

  • 10

Number

  • ARTN 107

Publisher

  • Biomed Central